52 Lyme St.
LYME/OLD LYME — On Thursday, Aug. 19, from 6:30 to 8 p.m., Lymes’ Youth Service Bureau (LYSB) and the Lyme/Old Lyme Prevention Coalition will be hosting a free Narcan and Question, Persuade, Refer (QPR) training session.
NARCAN (naloxone) is an opiate antidote. Opioids include heroin and prescription pain pills such as oxycodone, codeine and morphine. NARCAN is a prescription medicine that blocks the effects of opioids and reverses an overdose.
NARCAN® Nasal Spray may counteract the life-threatening effects of an opioid overdose. Since most accidental overdoses occur in a home setting, it was developed for first responders, as well as family, friends, and caregivers—with no medical training required. Its characteristics are:
- Needle-free
- Designed for ease-of-use in the community setting
- Inhalation not required
The Narcan training from 6:30 to 7 p.m. will provide participants with knowledge about overdose prevention strategies, administering Narcan, and support information and resources. Each participant will go home with a free Narcan kit.
The QPR portion from 7 to 8 p.m. will help participants learn the three steps to help save a life, warning signs of a suicide crisis, how to respond, and where to go for resources and support.
These sessions will be held at Old Lyme’s Memorial Town Hall. Register for one or both training sessions at this link.
Data indicates that emergency personnel are seeing a slight uptick in overdose calls in our region with state and national data showing that the pandemic has contributed to this rise.
Every week in the US, an average of 20 people die from a drug overdose, and eight by suicide. Accidental overdose is now the leading cause of death for Americans under 50, and suicide is the 10th leading cause of death.
This training is crucial if you ever find yourself in the position to save a life. It will be facilitated by staff from SERAC (Supporting and Engaging Resources for Action and Change).
For more information about the training sessions, visit this link.
Leave a Reply